Bigfoot Unity connected pen-cap system

Bigfoot Biomedical (Abbott)

An FDA-cleared US prescription system with active support information for existing users. It replaces the caps on rapid- and long-acting disposable pens; the rapid cap scans Libre 2 and displays clinician-programmed guidance. The current manufacturer site does not provide a public new-start ordering or enrolment pathway, so broad new-start retail access is unverified.

Available nowRegulator-approvedsmart-penmdiconnected-capdose-guidancecgm-integratedwhole-unitOfficial site ↗

The scorecard

Dose capture62

Both caps track dose timing when replaced on the pen, reducing forgotten injections, but the workflow is less complete than a pen that transmits exact dialed units automatically.[1]

Dose guidance82

The rapid cap shows clinician-programmed meal and correction suggestions using current glucose, trends, and recent insulin; it withholds correction advice when rapid insulin may still be active.[2]

CGM integration65

The white cap reads Libre 2 glucose and trend data directly, but requires an active scan at least every eight hours and does not support newer Libre or Dexcom sensors.[2]

Dose precision25

The FDA labeling explicitly excludes people who need half-unit doses.[1]

Low burden45

Advice appears on the pen cap, but two rechargeable caps, cap-specific pen fit, and eight-hour Libre scans create more upkeep than an integrated pen.[2]

Interoperability30

Multiple disposable insulin pens are supported through model-specific caps, but glucose integration is Libre 2 only and the system must not be used to control an AID system.[1]

Access & cost25

FDA-cleared and still supported for US users, with coverage varying by plan. The current manufacturer pages document product use and support but provide no public ordering or enrolment pathway; broad access for new starts is therefore unverified.[2]

These tools do not automate basal insulin. Scores reflect what the shipping product does for injection users: reliably capturing doses, turning glucose and insulin-on-board data into useful guidance, and reducing daily burden without hiding regional or insulin-cartridge lock-in.

The full picture

Bigfoot Unity puts glucose and dose advice on the insulin pen itself. A white cap replaces the cap on a compatible rapid-acting disposable pen; scanning its paired FreeStyle Libre 2 sensor shows glucose, trend, a clinician-programmed meal dose, and—when appropriate—a correction dose. A black cap for long-acting insulin shows the prescribed dose and time since the last injection.¹²

The trade-off is lock-in and upkeep. It uses Libre 2 only, requires a scan at least every eight hours to avoid data gaps, and a change of insulin pen may require a different cap. Both caps recharge by cable. It is not for half-unit dosing, more-than-once-daily long-acting insulin, pregnancy, dialysis, or people under 12 under its FDA labeling.²

Access needs a narrower claim. FDA clearance and a live customer-support site show that the system exists and that current users can obtain help. They do not prove that a new patient can order it today: Bigfoot's current pages provide no public new-start ordering, clinic-enrolment, or retail-pharmacy pathway. As of 8 August 2026, broad US access for new starts is therefore unverified, not assumed from the older clearance and launch materials.¹

There is also an open, narrow Class II recall worth separating from the whole product. In May 2025 Bigfoot recalled 57 identified caps running firmware 1.3.0 because a device error could make them unresponsive and remove information needed for a timely dosing decision. FDA recall Z-1997-2025 remained open when rechecked on 8 August 2026; this does not mean every Bigfoot Unity cap is recalled.³

Bigfoot Biomedical. Bigfoot Unity customer FAQs. https://www.bigfootbiomedical.com/customer/faqs.html ↩ ↩²
U.S. FDA. 510(k) decision summary K202145 — Bigfoot Unity Diabetes Management System. https://www.accessdata.fda.gov/cdrh_docs/reviews/K202145.pdf ↩ ↩²
U.S. FDA. Class II Device Recall Bigfoot Unity Diabetes Management System, Z-1997-2025. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=214046 ↩

Sources

[1]FDA 510(k) decision summary K202145 — Bigfoot Unity · regulatory · 2021-05-10
[2]Bigfoot Unity customer FAQ and current support information · manufacturer — Current instructions and customer-care details establish support for people using the system. The page does not provide a new-start ordering or enrolment route, so it cannot by itself establish broad retail access.
[3]FDA Class II recall Z-1997-2025 — Bigfoot Unity firmware 1.3.0 caps · regulatory · 2025-06-20 — Open as of 8 August 2026; 57 specific caps were recalled because a device error could leave the cap unresponsive. This is not a recall of every Bigfoot Unity cap.

References